Table 1.
Variable | N | Values |
---|---|---|
Age | ||
Mean | 91 | 39.37 |
Standard Deviation | ± 11.29 | |
Range | 20–62 | |
| ||
Stable Methadone Blocking Dose | ||
Mean | 85* | 111.98mg/day |
Standard Deviation | ± 60.80 | |
Range | 20–330 | |
| ||
Weeks to Stabilization | ||
Mean | 91 | 11.01 |
Standard Deviation | ± 9.38 | |
Range | 1–56** | |
| ||
Variable | N | Percentage |
| ||
Gender | ||
Female | 55 | 60.4% |
Male | 36 | 39.6% |
| ||
Race/Ethnicity | ||
African America | 12 | 13.5% |
Caucasian | 70 | 78.7% |
Hispanic | 6 | 6.7% |
Other | 1 | 1.1% |
| ||
Opiate Route of Administration⋄ | ||
Intravenous | 67.8 % | |
Oral | 91 | 50% |
Intranasal | 49.4% | |
Combination of ≥ 2 of the Above | 38.9% | |
| ||
History of Illicit Drug Use: Lifetime+⋄ | ||
Marijuana | 91 | 71.5% |
Stimulants | 64.8% | |
Benzodiazepines | 70.3% | |
Combination of ≥ 2 of the Above | 80.2% | |
| ||
History of Illicit Drug Use: Recent+⋄ | ||
Marijuana | 42%++ | |
Stimulants | 91 | 39.3% |
Benzodiazepines | 51.7% | |
Combination of ≥ 2 of the Above | 46.6% |
6 individuals did not stabilize within the initial 9 month period
only data from those that stabilized within the initial 9 month period were considered.
values do not sum to 100% due to poly-drug use.
in addition to opiates
values may be biased by purposeful sampling for cannabis use while in treatment.